Actualités 18. Mai 2021 Le Start-Up Fund du Biopôle veut favoriser un accès précoce à l’innovation dans les sciences de la vie Biopôle a annoncé le lancement du « Biopôle Start-Up Fund », un nouveau fonds dédié au soutien de la prochaine génération d’entrepreneurs dans le...
News 18. Mai 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
News 30. Nov. 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
News 06. Juli 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News 11. Mai 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...
News 08. März 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
Third Party Event Philippines and Switzerland: Investing Together for a Better Future Bern Switzerland
News 09. Febr. 2021 Pharmaceutical and biotech expert ZETA opens a new subsidiary in the canton of Valais ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business
Third Party Event Colombia and its regions: business and investment opportunities in a transformed emerging market Genève Switzerland
News 25. Juni 2018 Chinese pharmaceutical firm Beijing Tong Ren Tang sets up presence in Geneva The newest addition to Western Switzerland’s Health Valley is one of the oldest, largest and most prominent traditional Chinese medicine companie...
News 27. Apr. 2018 Five reasons to register for the Aussenwirtschaftsforum now The Switzerland Global Enterprise Aussenwirtschaftsforum is the annual meeting of the Swiss export economy. Why is this year's event unmissable f...
Aktuell 30. Nov. 2021 Hemex erhält 7,1 Millionen Franken Hemex hat in einer Serie C-Finanzierungsrunde insgesamt 7,1 Millionen Franken eingeworben. Das Unternehmen für klinische Auftragsforschung und In...
Aktuell 10. Nov. 2021 Kollagenmembran von Geistlich Pharma erhält Zulassung in den USA Geistlich Nexo-Gide hat die Zulassung der amerikanischen Aufsichtsbehörde erhalten. Die von Geistlich Pharma entwickelte Kollagenmembran unterstü...
Analyse 22. März 2021 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
Fallstudie 11. Nov. 2020 Effektivität der Schweizer Freihandelsabkommen (FHA) weltweit Evaluierung der FHA-Nutzung durch Schweizer-Exporteure